what is the highest dosage of semaglutide Dosing & Prescribing

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes side effects of Ozempic (semaglutide), a GLP 1 receptor agonist widely used for the management of type 2 diabetes mellitus and for weight loss. Common side effectsprimarily gastrointestinalinclude nausea, vomiting, diarrhea, constipation, abdominal The U.S. Food and Drug Administration approved Eli Lilly's GLP 1 pill, the company said, a major milestone for the Indianapolis based drugmaker and one that will test the market for new weight loss medications. Sunlight GLP 1 2026: Compounded Semaglutide From $159, What FDA's June 2026 Decision Means for Compounded Best Retatrutide Research UK (2026): Triple Agonist Guide GLP 1 Activator Diabetic Warehouse